Evofem Biosciences, Inc.
For the period ended Oct 29, 2025. Filed Oct 29, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Oct 29, 2025 · Filed Oct 29, 2025
Use the contents to explore the available documents and sections.
Contents
Additional Information
The Company files reports, proxy statements/prospectuses, and other information with the SEC as required by the Exchange Act. You can read the Company’s SEC filings, including this proxy, through the SEC’s website at http://www.sec.gov and via https://evofem.investorroom.com/SEC-filings.
If you would like additional printed copies of this proxy statement or if you have questions about the proposals to be presented at the Annual Meeting, you should contact us by telephone or in writing:
Evofem Biosciences, Inc.
7770 Regents Road
Suite 113-618
San Diego, CA 92122
Telephone: 858-550-1900
If you are a stockholder of Evofem and would like to request documents, please do so by November 17, 2025 to receive them before the Annual Meeting. If you request any documents from us, we will mail them to you by first class mail or another equally prompt means.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.